$2.45
0[0.00%]
At close: Apr 26
$2.45
0[0.00%]
PreMarket: 6:23PM EDT
Heron Therapeutics
(NASDAQ:HRTX)Heron Therapeutics Stock (NASDAQ:HRTX), Guidance and Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Date Announced | ticker | Company Name | Period | Period Year | Min EPS | Max EPS | Estimate | Min Rev | Max Rev | Revenue Estimate | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/12/2024 | HRTX | Heron Therapeutics | FY | 2024 | — | — | — | $138.00M | $158.00M | $139.10M | Get Alert |
| 11/14/2023 | HRTX | Heron Therapeutics | FY | 2023 | — | — | — | $123.00M | $125.00M | $124.61M | Get Alert |
| 11/14/2023 | HRTX | Heron Therapeutics | FY | 2024 | — | — | — | $138.00M | $158.00M | $156.57M | Get Alert |
| 11/08/2022 | HRTX | Heron Therapeutics | FY | 2022 | — | — | — | $93.00M | $95.00M | $107.14M | Get Alert |
| 08/09/2022 | HRTX | Heron Therapeutics | FY | 2022 | — | — | — | $93.00M | $95.00M | $106.69M | Get Alert |
FAQ
What is the most recent guidance for Heron Therapeutics (HRTX)?
There have been no specific sales or earnings guidance reported for Heron Therapeutics in recent months.
Browse guidance and forecast on all stocks.